Literature DB >> 2125405

Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.

A M Dalzell1, H K van Saene, D P Heaf.   

Abstract

We used an oral topical antibiotic preparation to try and prevent oropharyngeal carriage of Pseudomonas aeruginosa in patients with cystic fibrosis. Ten of 15 patients treated with a two week course of intravenous ceftazidime together with a 90 day course of an antibiotic containing gel continued to carry P aeruginosa in the oropharynx.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2125405      PMCID： PMC1793124          DOI： 10.1136/adc.65.12.1365

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  4 in total

1.  Selective decontamination.

Authors:  H K van Saene; C P Stoutenbeek
Journal:  J Antimicrob Chemother       Date:  1987-10       Impact factor: 5.790

2.  Nosocomial gram-negative pneumonia in critically ill patients. A 3-year experience with a novel therapeutic regimen.

Authors:  C P Stoutenbeek; H K van Saene; D R Miranda; D F Zandstra; D Langrehr
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

3.  Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis.

Authors:  M E Hodson; A R Penketh; J C Batten
Journal:  Lancet       Date:  1981-11-21       Impact factor: 79.321

4.  Oral colonization and susceptibility testing of Pseudomonas aeruginosa oral isolates from cystic fibrosis patients.

Authors:  R A Lindemann; M G Newman; A K Kaufman; T V Le
Journal:  J Dent Res       Date:  1985-01       Impact factor: 6.116
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.